Clinical Trial Update: A Study of Selumetinib in Patients With Kaposi's Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of Selumetinib for Kaposi's sarcoma in AIDS-related cases has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Selumetinib (selumetinib)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: AIDS-related Kaposi's Sarcoma | Phase 1, Phase 2 | Status: TERMINATED